Fecal Immunochemical Test
7
1
1
1
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 85/100
14.3%
1 terminated out of 7 trials
50.0%
-36.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (7)
Pragmatic Mobile Health Trial to Promote Cancer Screening and Healthy Behaviors
Implementation Intention Planning Guide for FIT Colon Cancer Screening
Optimal Surveillance Strategy After Positive FIT and Negative Colonoscopy
Head to Head Trial of Mailed Cologuard to Mailed FIT
Comparison of the Performance Between Conventional Colonoscopy and 3D Colonoscopy in Positive Fecal Immunochemical Test Group
WhatsApp Reminder on FIT Compliance
Efficacy of Fecal Immunochemical Test Using Digital Rectal Exam